Meta Pixel

News and Announcements

Capital Raising: Mastering the 3 Stages of the Buying Process

  • Published August 08, 2023 11:00PM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

As a startup founder, raising capital is a critical part of your journey. Understanding the science behind the capital raising process can significantly enhance your efforts. There are many layers involved in this process, and one of the most important aspects is understanding the buying process. This article will delve into the three stages of the buying process: awareness, consideration, and decision-making.

YouTube player

Stage 1: Awareness – Creating Momentum

The first stage of the buying decision is awareness. This is where you make potential investors aware of your startup and its value proposition. It’s crucial to leverage key brand points and create a strong visibility in the market. This stage is all about gaining momentum and attracting investors.

Effective communication is key during the awareness stage. It’s important to identify potential investors and communicate your startup’s vision, mission, and unique selling points. Remember, the goal is not just to inform but also to intrigue and attract those most likely to become shareholders.

Stage 2: Consideration – The Bandwagon Effect

The second stage is consideration. This is where potential investors evaluate your startup and consider whether or not to invest. The psychology of investors plays a significant role in this stage. Investors typically do not want to be the first to invest, nor do they want to miss out on promising opportunities. This leads to a phenomenon known as the bandwagon effect, where many investors tend to invest together.

Having a lead investor or a renowned investor can trigger the bandwagon effect. Venture capitalists, family offices, and high net worth individuals often prefer to invest together with other friends, networks, or colleagues they have previously done deals with. Therefore, securing a lead investor can be a game-changer in your capital raising efforts.

Stage 3: Decision-Making – Setting a Deadline

The final stage of the buying process is decision-making. This is where potential investors make their final decision to invest in your startup. Interestingly, humans tend to delay tasks until a deadline is set. Once a deadline is in place, our minds start working towards it. This principle applies to both individuals and companies.

In the context of capital raising, the first closing of a fund creates a deadline and puts pressure on investors to make a decision. Therefore, setting a deadline and working towards it is crucial to finalise the capital raise.

Understanding and navigating the three stages of the buying decision – awareness, consideration, and decision-making – can significantly enhance your capital raising efforts. Each stage has its unique characteristics and requires a different approach. By mastering these stages, you can make your capital raising process more efficient and effective, ultimately leading to the growth and success of your startup.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now